North American Magnetoencephalograph (MEG) Market Research Report
- Report Code: MA 1001
- Publish Date: Upcoming
Magnetoencephalography (MEG) refers to a non-invasive neurophysiological method, which helps measure the magnetic fields generated by the neuronal activities of a person’s brain. In other words, it is a unique and effective diagnostic tool used to evaluate the brain function. The increasing incidence of brain disorders among the aging population in North America is responsible for the increase in demand for MEG and other brain monitoring devices in this region.
North American is the largest contributor to the global MEG market, having accounted for a share of 52.27% in 2013. The North American market is projected to grow at a CAGR of 7% from 2013 to 2018. The U.S. is the most important segment in the North American MEG market, after recording an undisputable market share of 91.8% in 2013. The market has also been analyzed in terms of the main applications of MEG, namely brain research studies and autistic disorders. The brain research studies segment is an essential consumer of MEG systems, having accounted for a 55.0% share of the North American market in 2013. The Health Sciences Center (Denver), Brain Sciences Center (Minneapolis), and Montreal Neurological Institute (Montreal, Canada) among others, are some of the important institutions to have adopted magnetoencephalography systems for diagnosis of brain disorders.
The aging population in North America constitutes over 40% of the overall population in this region, and the incidences of mental/brain disorders have grown steadily in recent years. This is one of the most important factors driving the demand for MEG and other brain monitoring devices in this region. In addition to this, investments made into the research & developmental activities in the field of mental health have also been increasing significantly. Growing investments, along with rising compliance and acceptance of patients, are the major driving factors of the North American MEG market. The major companies that are contributing to the growth of the North American market include Elekta (Sweden) and Yokogawa Electric Corporation (Japan) among others.
The North American magnetoencephalography market report provides insights into the segmentation of the concerned market. The North American market has been segmented in terms of application, end-user, and geography. On the basis of end-users, the market has been segmented into home care providers and hospitals. The main applications of MEG systems include autistic disorders and brain research studies. The U.S., Canada, and Mexico are the major countries that have been considered for this extensive market analysis. The report also provides details of the competitive landscape and profiles of the key players in the North American magnetoencephalography market.
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Brain Monitoring Devices The North American Brain Monitoring Devices Market, mainly driven by rising incidences of autoimmune and cardiovascular diseases, brain disorders and sleep disorders which was valued at $1119.6 million in 2012 and is poised to grow at a CAGR of 9.0% to reach $1834.0 million by 2018. North American Brain Monitoring Devices market segmented by product such as Electroencephalograph, Transcranial Doppler, Magnetoencephalograph, Intracranial Pressure Monitor, Cerebral Oximeter, and Acessories. The major players extensively covered in this report are Nihon Kohden Corporation, Nonin Medical Inc, Elekta AB, Yokogawa, Grass Technologies, Compumedics Ltd, Cadwell Laboratories |
Upcoming |
|
|
European Brain Monitoring Devices The European Brain monitoring Devices Market, mainly driven by rising incidences of autoimmune and cardiovascular diseases, brain disorders and sleep disorders. The European Brain monitoring market was valued at $279.9 million in 2012 and is poised to grow at a CAGR of 8.6% to reach $458.5 million by 2018. The European Brain monitoring Devices market segmented by product such as Electroencephalograph, Transcranial Doppler, Magnetoencephalograph, Intracranial Pressure Monitor, Cerebral Oximeter, and Acessories. The main companies operating in Brain monitoring devices market and extensively covered in this report are Nihon Kohden Corporation, Nonin Medical Inc, Elekta AB, and Advanced Brain monitoring, Inc., Yokogawa, Grass Technologies, Compumedics Ltd, Cadwell Laboratories |
Upcoming |
|
|
Asian Brain Monitoring Devices The Asian Brain Monitoring Devices Market, mainly driven by rising incidences of autoimmune and cardiovascular diseases, brain disorders and sleep disorders. The Asian brain monitoring market was valued at $162.3 million in 2012 and is poised to grow at a CAGR of 9.2% to reach $275.1 million by 2018. The Asian Brain Monitoring Devices market segmented by product such as Electroencephalograph, Transcranial Doppler, Magnetoencephalograph, Intracranial Pressure Monitor, Cerebral Oximeter, and Acessories. The main companies operating in the Asian brain monitoring devices market and extensively covered in this report are Nihon Kohden Corporation, Nonin Medical Inc, Elekta AB, and Advanced Brain Monitoring, Inc., Yokogawa, Grass Technologies, Compumedics Ltd, Cadwell Laboratories |
Upcoming |
